期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
Production of interleukin-1β related to mammalian target of rapamycin/Toll-like receptor 4 signaling pathway during Aspergillus fumigatus infection of the mouse cornea 被引量:6
1
作者 Rui Xu Jing Lin +4 位作者 Gui-Qiu Zhao Cui Li Cheng-Ye Che Qiang Xu Min Liu 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2018年第5期712-718,共7页
AIM:To elucidate the effect of rapamycin on regulating the production of interleukin(IL)-1β in Aspergillus fumigatus(A.fumigatus)-induced keratitis and to verify whether the expression of IL-1β in A.fumigatus k... AIM:To elucidate the effect of rapamycin on regulating the production of interleukin(IL)-1β in Aspergillus fumigatus(A.fumigatus)-induced keratitis and to verify whether the expression of IL-1β in A.fumigatus keratitis is associated with the mammalian target of rapamycin(mT OR)/Toll-like receptor 4(TLR4) signaling pathway.METHODS:Fungal keratitis mouse models of susceptible C57 BL/6 mice were established using A.fumigatus.The mice were subsequently treated with rapamycin.The protein levels of p-mT OR,TLR4,and IL-1β in normal and infected corneal tissue were measured by Western blot.The TLR4 and IL-1β m RNA levels were determined by real-time polymerase chain reaction(PCR).RESULTS:In C57 BL/6 mice,rapamycin treatment decreased the clinical scores and production of the pro-inflammatory cytokine,IL-1β.The expression of TLR4,stimulated by A.fumigatus,was reduced as well when the mT OR signaling pathway was suppressed by rapamycin.CONCLUSION:Rapamycin is beneficial for the outcome of fungal keratitis and has an inhibitory effect expression of the inflammatory cytokine IL-1β.The inhibitory effect on IL-1β expression can be associated with the mT OR/TLR4 signaling pathway in A.fumigatus infection in mice. 展开更多
关键词 KERATITIS INTERLEUKIN-1Β mammalian target of rapamycin Toll-like receptor 4 mice
下载PDF
橙皮素抑制TLR4-mTOR-ULK1信号通路对心肌缺血再灌注损伤大鼠细胞自噬和凋亡的影响
2
作者 张卫丰 马海龙 张金玲 《实用检验医师杂志》 2024年第2期133-138,共6页
目的 探讨橙皮素(HES)对心肌缺血再灌注损伤(MIRI)大鼠细胞自噬与凋亡的影响,并初步分析其机制。方法 将SD大鼠分为假手术(Sham)组、MIRI组、低剂量HES(HES-L,15 mg/kg)组、高剂量HES(HES-H,30 mg/kg)组和HES-H+Toll样受体4(TLR4)抑制剂... 目的 探讨橙皮素(HES)对心肌缺血再灌注损伤(MIRI)大鼠细胞自噬与凋亡的影响,并初步分析其机制。方法 将SD大鼠分为假手术(Sham)组、MIRI组、低剂量HES(HES-L,15 mg/kg)组、高剂量HES(HES-H,30 mg/kg)组和HES-H+Toll样受体4(TLR4)抑制剂(HES 30 mg/kg+复合物C 0.2 mg/kg)组。连续给药7 d,除Sham组外,大鼠采用冠脉结扎法构建MIRI模型,24 h后检测左心室血流动力学参数[包括左室舒张期末压(LVEDP)、左室内压最大上升速率(dp/dtmax)、左室内压最大下降速率(-dp/dtmax)];采用原位末端转移酶标记技术(TUNEL)检测心肌细胞凋亡,氯化三苯基四氮唑(TTC)染色检测心肌梗死(心梗)面积,酶联免疫吸附试验(ELISA)检测心肌组织中丙二醛(MDA)、超氧化物歧化酶(SOD);Western blotting检测大鼠心肌组织中微管相关蛋白1-轻链3(LC3)Ⅱ、LC3Ⅰ、自噬效应蛋白(Beclin1)、TLR4、磷酸化(p)-TLR4、雷帕霉素靶蛋白(mTOR)、p-mTOR、unc-51样自噬激活激酶1(ULK1)、p-ULK1蛋白表达。结果 与Sham组比较,MIRI组大鼠心肌细胞线粒体损伤、自噬空泡形成;LVEDP[mmHg(1 mmHg≈0.133 kPa):14.22±2.12比5.44±0.83]、心肌细胞凋亡率[(31.52±4.01)%比(2.41±0.26)%]、心梗面积(mm2:43.68±3.86比0.00)、心肌组织MDA(ng/L:8.25±1.03比3.71±0.65)、p-mTOR/mTOR(0.76±0.08比0.33±0.04)、p-ULK1/ULK1(0.69±0.08比0.22±0.03)均显著升高,dp/dtmax(mmHg/s:3 441.43±289.25比4 910.57±350.12)、-dp/dtmax(mmHg/s:2 588.96±260.23比3 845.94±364.19)、心肌组织LC3Ⅱ/LC3Ⅰ(1.13±0.14比2.35±0.21)、Beclin1(0.35±0.06比0.87±0.09)、p-TLR4/TLR4(0.40±0.05比0.84±0.10)均显著降低(均P <0.05)。与MIRI组比较,HES-L、HES-H组大鼠线粒体损伤缓解,自噬空泡少见;LVEDP(mmHg:11.56±1.60、7.88±1.21比14.22±2.12)、心肌细胞凋亡率[(25.52±3.11)%(、17.54±1.89)%比(31.52±4.01)%]、心梗面积(mm2:36.67±3.58、29.58±3.04比43.68±3.86)、心肌组织MDA(ng/L:6.98±0.65、4.12±0.48比8.25±1.03)、p-m TOR/m TOR(0.60±0.07、0.45±0.05比0.76±0.08)、p-ULK1/ULK1(0.54±0.05、0.32±0.04比0.69±0.08)均显著降低,dp/dtmax(mmHg/s:3 972.82±310.17、4 442.97±396.24比3 441.43±289.25)、-dp/dtmax(mmHg/s:3 152.30±312.18、3 430.57±324.24比2 588.96±260.23)、心肌组织中LC3Ⅱ/LC3Ⅰ(1.76±0.18、2.01±0.20比1.13±0.14)、Beclin1(0.56±0.07、0.79±0.08比0.35±0.06)、p-TLR4/TLR4(0.55±0.06、0.73±0.08比0.40±0.05)均显著升高(均P <0.05)。结论 HES可通过抑制TLR4-m TOR-ULK1信号通路促进MIRI大鼠心肌细胞自噬,抑制凋亡。 展开更多
关键词 心肌缺血再灌注损伤 橙皮素 Toll样受体4 雷帕霉素靶蛋白 unc-51样自噬激活激酶1 自噬 凋亡
下载PDF
Transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption
3
作者 Mengyi Yan Xiayun Chen +9 位作者 Xiaotong Li Qianqian Liu Baixue Yu Yi Cen Wei Zhang Yibin Liu Xinxuan Li Ying Chen Tao Wang Shiying Li 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第9期4118-4133,共16页
The immunosuppressive phenotype of tumor cells extensively attenuates the immune activation effects of traditional treatments.In this work,a transferrin receptor(TfR)targeted immunostimulant(PTI)is fabricated for phot... The immunosuppressive phenotype of tumor cells extensively attenuates the immune activation effects of traditional treatments.In this work,a transferrin receptor(TfR)targeted immunostimulant(PTI)is fabricated for photodynamic immunotherapy against metastatic tumors by interrupting β-catenin signal pathway.To synthesize PTI,the photosensitizer conjugated TfR targeting peptide moiety(Palmitic-K(PpIX)-HAIYPRH)is unitized to encapsulate the transcription interrupter of ICG-001.On the one hand,the recognition of PTI and TfR can promote drug delivery into tumor cells to destruct primary tumors through photodynamic therapy and initiate an immunogenic cell death with the release of tumorassociated antigens.On the other hand,PTI will interrupt the binding between b-catenin andcAMP response element-binding protein(CREB),regulating the gene transcription to downregulate programmed death ligand 1(PD-L1)while upregulating CeC motif chemokine ligand 4(CCL4).Furthermore,the elevated CCL4 can recruit the dendritic cells to present tumor-specific antigens and promote T cells activation and infiltration,and the downregulated PD-L1 can avoid the immune evasion of tumor cells and activate systemic anti-tumor immunity to eradicate lung metastasis.This work may inspire the development of antibody antibody-free strategy to activate systemic immune response in consideration of immunosuppressive conditions. 展开更多
关键词 Transferrin receptor β-Catenin signal pathway Tumor targeting Photodynamic therapy IMMUNOTHERAPY Immunogenic cell death Programmed death ligand 1 C-C motif chemokine ligand 4
原文传递
二肽基肽酶-4通过CXCR4/mTOR信号通路介导小鼠肺泡巨噬细胞MH-S自噬的机制研究 被引量:2
4
作者 杨帆 邓璐 陈睦虎 《中国现代医学杂志》 CAS 北大核心 2022年第16期7-13,共7页
目的探究二肽基肽酶-4(DPP-4)通过趋化因子受体4(CXCR4)/哺乳动物雷帕霉素靶蛋白(mTOR)信号通路介导小鼠肺泡巨噬细胞MH-S自噬的机制。方法体外培养小鼠肺泡巨噬细胞MH-S并分组转染。分别设置PBS组(PBS培养MH-S细胞)、LPS组(100 ng/mL ... 目的探究二肽基肽酶-4(DPP-4)通过趋化因子受体4(CXCR4)/哺乳动物雷帕霉素靶蛋白(mTOR)信号通路介导小鼠肺泡巨噬细胞MH-S自噬的机制。方法体外培养小鼠肺泡巨噬细胞MH-S并分组转染。分别设置PBS组(PBS培养MH-S细胞)、LPS组(100 ng/mL LPS诱导24 h)、DPP-4组(DPP-4表达病毒转染)、si-DPP-4组(si-DPP-4病毒载体转染)、DPP-4+BafA1组(DPP-4表达病毒转染+自噬抑制剂BafA1干预)及si-DPP-4+BafA1组(si-DPP-4病毒载体转染+自噬抑制剂BafA1干预)。绿色荧光蛋白(GFP)检测转染效率,稳定转染后,酶联免疫吸附试验检测MH-S细胞上清液炎症因子水平,腺病毒检测MH-S细胞自噬流变化,实时荧光定量聚合酶链反应检测细胞DPP-4、CXCR4、mTOR mRNA的表达,Western blottig检测CXCR4/mTOR通路蛋白的表达。结果LPS组IL-1β、IL-6、TNF-α、GFP、RPF、Merge数量,CXCR4mRNA、mTOR mRNA和CXCR4蛋白、p-mTOR/mTOR蛋白相对表达量高于PBS组(P<0.05);DPP-4组与LPS组IL-1β、IL-6及TNF-α水平比较,差异无统计学意义(P>0.05);DPP-4组GFP、RPF、Merge数量,DPP-4 mRNA相对表达量高于LPS组(P<0.05),CXCR4 mRNA、mTOR mRNA、CXCR4蛋白、pmTOR/mTOR蛋白相对表达量低于LPS组(P<0.05);si-DPP-4组IL-1β、IL-6、TNF-α水平高于LPS组(P<0.05),GFP、RPF及MergeMerge数量低于LPS组(P<0.05);si-DPP-4组和DPP-4+BafA1组IL-1β、IL-6、TNF-α水平、CXCR4蛋白、p-mTOR/mTOR蛋白相对表达量高于DPP-4组(P<0.05),GFP、RPF及Merge数量低于DPP-4组(P<0.05);si-DPP-4组DPP-4 mRNA相对表达量低于DPP-4组(P<0.05),CXCR4 mRNA、mTOR mRNA相对表达量高于DPP-4组(P<0.05);si-DPP-4+BafA1组IL-1β、IL-6水平、CXCR4 mRNA、mTOR m RNA、CXCR4蛋白、p-mTOR/mTOR蛋白相对表达量高于si-DPP-4组(P<0.05),GFP、RPF、Merge数量低于si-DPP-4组(P<0.05)。结论DPP-4能够调节小鼠肺巨噬细胞自噬作用,调控炎症反应,其作用机制可能与CXCR4/mTOR通路有关。 展开更多
关键词 肺泡巨噬细胞 自噬 二肽基肽酶-4 趋化因子受体4/哺乳动物雷帕霉素靶蛋白通路 小鼠
下载PDF
mTOR和CCR7与乳腺癌侵袭转移的关系
5
作者 刘清华 李媛媛 +2 位作者 徐滨 王竹青 刘雨清 《国际病理科学与临床杂志》 CAS 2013年第2期93-97,共5页
目的:探讨乳腺浸润性导管癌组织中哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)与趋化因子受体7(chemokine receptor 7,CCR7)蛋白的表达,以及二者与乳腺癌侵袭、转移之间的关系。方法:采用免疫组织化学方法检测65例乳... 目的:探讨乳腺浸润性导管癌组织中哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)与趋化因子受体7(chemokine receptor 7,CCR7)蛋白的表达,以及二者与乳腺癌侵袭、转移之间的关系。方法:采用免疫组织化学方法检测65例乳腺浸润性导管癌及32例正常乳腺组织中mTOR和CCR7的表达情况,并分析二者之间的相关性及其与各临床病理特征之间的关系。结果:mTOR和CCR7蛋白在乳腺浸润性导管癌中的阳性表达率(mTOR为68%,CCR7为74%)高于癌旁正常乳腺组织中的阳性表达率(mTOR为25%,CCR7为28%),差异有统计学意义(P<0.01)。mTOR与CCR7的表达呈正相关(r=0.485,P<0.05)。mTOR和CCR7的高表达均与淋巴结转移、临床恶性肿瘤分期有关(均P<0.05),而与年龄、雌激素受体、孕激素受体无关(均P>0.05)。结论:mTOR和CCR7的异常高表达可能与乳腺癌的侵袭、转移有关,且检测二者的表达可作为判断乳腺癌转移的预测指标。 展开更多
关键词 哺乳动物雷帕霉素靶蛋白 趋化因子受体7 乳腺浸润性导管癌 免疫组织化学 侵袭 转移
下载PDF
Hepatitis C virus infection and insulin resistance 被引量:9
6
作者 Sandip K Bose Ranjit Ray 《World Journal of Diabetes》 SCIE CAS 2014年第1期52-58,共7页
Approximately 170 million people worldwide are chronically infected with hepatitis C virus(HCV).Chronic HCV infection is the leading cause for the development of liver fibrosis,cirrhosis,hepatocellular carcinoma(HCC)a... Approximately 170 million people worldwide are chronically infected with hepatitis C virus(HCV).Chronic HCV infection is the leading cause for the development of liver fibrosis,cirrhosis,hepatocellular carcinoma(HCC)and is the primary cause for liver transplantation in the western world.Insulin resistance is one of the pathological features in patients with HCV infection and often leads to development of typeⅡdiabetes.Insulin resistance plays an important role in the development of various complications associated with HCV infection.Recent evidence indicates that HCV associated insulin resistance may result in hepatic fibrosis,steatosis,HCC and resistance to anti-viral treatment.Thus,HCV associated insulin resistance is a therapeutic target at any stage of HCV infection.HCV modulates normal cellular gene expression and interferes with the insulin signaling pathway.Various mechanisms have been proposed in regard to HCV mediated insulin resistance,involving up regulation of inflammatory cytokines,like tumor necrosis factor-α,phosphorylation of insulin-receptor substrate-1,Akt,up-regulation of gluconeogenic genes like glucose 6 phosphatase,phosphoenolpyruvate carboxykinase 2,and accumulation of lipid droplets.In this review,we summarize the available information on how HCV infection interferes with insulin signaling pathways resulting in insulin resistance. 展开更多
关键词 Hepatitis C virus INSULIN resistance INSULIN receptor substrate 1 Protein kinase B mammalian tar-get of rapamycin/S6K1 SUPPRESSOR of cytokine signal-ing 3 Glucose transporter-4 Lipid metabolism ANTI-VIRAL therapy
下载PDF
转移性激素受体阳性乳腺癌内分泌治疗耐药及治疗决策进展 被引量:1
7
作者 穆颖 陈奕至 卢敏 《肿瘤综合治疗电子杂志》 2018年第3期29-36,共8页
内分泌治疗已成为转移性激素受体(hormone receptor,HR)阳性乳腺癌的治疗基础。内分泌耐药的发生使得很多新型内分泌治疗药物或药物组合被研发出来。细胞周期蛋白依赖性激酶(cyclin-dependent protein kinase,CDK)4/6抑制剂的应用可显... 内分泌治疗已成为转移性激素受体(hormone receptor,HR)阳性乳腺癌的治疗基础。内分泌耐药的发生使得很多新型内分泌治疗药物或药物组合被研发出来。细胞周期蛋白依赖性激酶(cyclin-dependent protein kinase,CDK)4/6抑制剂的应用可显著延长内分泌耐药患者的无进展生存时间。有多项关于使用磷脂酰肌醇3激酶(phosphatidylinositol 3-kinase,PI3K)抑制剂和哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)抑制剂作为后续治疗方案的研究,特别是针对内分泌耐药的情况,应基于合并症、既往辅助治疗、患者的生活质量、不良反应及无病间隔期的情况,选择治疗方案的最佳顺序。对转移性乳腺癌的特定生物标志物检测以及新型基因检测对预测治疗效果、耐药性以及预后均具有重要意义,有助于进一步推动精准治疗的发展。 展开更多
关键词 转移性乳腺癌 激素受体阳性乳腺癌 内分泌治疗耐药 CDK4/6抑制剂 磷脂酰肌醇3激酶抑制剂 哺乳动物雷帕霉素靶蛋白抑制剂
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部